Total Lesion Glycolysis Using ¹⁸F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer

Journal of Korean Medical Science
Ji Hyung HongIe Ryung Yoo

Abstract

Standardized uptake value (SUV), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) have been considered prognostic factors for survival in many cancers. However, their prognostic value for radiotherapy-treated squamous esophageal cancer has not been evaluated. In this study, SUV, MTV, and TLG were measured to predict their prognostic role in overall survival (OS) in 38 esophageal cancer patients who had undergone (18)F-FDG PET/CT before radiotherapy. TLG demonstrated higher sensitivity and specificity for predicting OS than MTV and SUV; and a better OS was observed in patients with low TLG compared to those with high TLG in locally advanced disease (OS, 46.9 months; 95% confidence interval [CI], 33.50-60.26 vs. 25.3 months; 95% CI, 8.37-42.28; P=0.003). Multivariate analyses in these patients determined that TLG and the use of combination chemotherapy were the independent prognostic factors for OS (hazard ratio [HR], 7.12; 95% CI, 2.038-24.857; P=0.002 and HR, 6.76; 95% CI, 2.149-21.248; P=0.001, respectively). These results suggest that TLG is an independent prognostic factor for OS and a better predictor of survival than MTV and SUV in patients with locally advanced esophageal cancer treated with radiotherapy.

References

Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael StahlHansjochen Wilke
Jun 21, 2005·International Journal of Radiation Oncology, Biology, Physics·Si Yeol SongEun Kyung Choi
Nov 7, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Andrew DaviesTom Treasure
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Sep 29, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Shengri LiaoYonglin Pu
Jan 4, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mathieu HattCatherine Cheze Le Rest
Apr 12, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Elizabeth H DibbleRathan M Subramaniam
Jan 17, 2013·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Seung Hwan MoonJoon Young Choi
Mar 23, 2013·Journal of Radiation Research·Kazushige AtsumiHiroshi Honda
Jul 25, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Eun-Seok ChoiIlkyu Han
Sep 1, 2012·Nuclear Medicine and Molecular Imaging·Jang YooByung-Tae Kim

❮ Previous
Next ❯

Citations

Jan 14, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Masatoshi HottaKazuhiko Yamada
Mar 2, 2021·Frontiers in Immunology·Trust OdiaUNKNOWN Catalysis TB-Biomarker Consortium
Oct 10, 2021·Annals of Surgical Oncology·M Hart SquiresJonathan C Salo

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
dissection

Software Mentioned

Mirada XD3
RECIST
SPSS

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.